Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications
Conclusions
Our results strongly suggest that bone turnover inhibitors, OPG and sclerostin, are independently associated with CAC with potential additive effects in ND-CKD patients.
Source: Nephrology Dialysis Transplantation - Category: Urology & Nephrology Authors: Morena, M., Jaussent, I., Dupuy, A.-M., Bargnoux, A.-S., Kuster, N., Chenine, L., Leray-Moragues, H., Klouche, K., Vernhet, H., Canaud, B., Cristol, J.-P. Tags: Chronic Kidney Disease Source Type: research
More News: Chronic Kidney Disease | CT Scan | Diabetes | Dialysis | Endocrinology | Kidney Transplant | Kidney Transplantation | Smokers | Study | Transplants | Urology & Nephrology